Lucitanib
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Lucitanib, covering 2020-06-23 to 2024-07-25. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer [Phase 2]